Cell-based therapies for age-related macular degeneration: cell replacement versus paracrine effects
نویسندگان
چکیده
منابع مشابه
Stem cell-based therapies for age-related macular degeneration: current status and prospects.
Age-related macular degeneration (AMD) is one of the major causes of irreversible blindness both in developed and developing countries. During the past decades, the managements of neovascular AMD (wet AMD) have dramatically progressed. However, still no effective treatment for non-neovascular AMD (dry AMD) which was characterized by geographic macular atrophy. Recent advances in stem cell scien...
متن کاملChoice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A Review
Background. Age-related macular degeneration (AMD) is a complex disorder that affects primarily the macula involving the retinal pigment epithelium (RPE) but also to a certain extent the photoreceptor layer and the retinal neurons. Cell transplantation is a promising option for AMD and clinical trials are underway using different cell types. Methods. We hypothesize that instead of focusing on a...
متن کاملStem cell therapies for age-related macular degeneration: the past, present, and future
In the developed world, age-related macular degeneration (AMD) is one of the major causes of irreversible blindness in the elderly. Although management of neovascular AMD (wet AMD) has dramatically progressed, there is still no effective treatment for nonneovascular AMD (dry AMD), which is characterized by retinal pigment epithelial (RPE) cell death (or dysfunction) and microenvironmental disru...
متن کاملGene Therapies for Neovascular Age-Related Macular Degeneration.
Pathological neovascularization is a key component of the neovascular form (also known as the wet form) of age-related macular degeneration (AMD) and proliferative diabetic retinopathy. Several preclinical studies have shown that antiangiogenesis strategies are effective for treating neovascular AMD in animal models. Vascular endothelial growth factor (VEGF) is one of the main inducers of ocula...
متن کاملNew Antiangiogenic Therapies for Age-related Macular Degeneration
New targeted pharmacologic approaches for the management of age-related macular degeneration (AMD) are based on inhibiting pathologic angiogenesis, which underlies choroidal neovascularization. These new therapies improved results obtained with photodynamic therapy alone. Two antivascular endothelial growth factor (anti-VEGF) drugs have been approved for the treatment of neovascular AMD, and se...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neural Regeneration Research
سال: 2021
ISSN: 1673-5374
DOI: 10.4103/1673-5374.300443